KRAS and lung cancer: For instance, ATM [36] deficient or constitutive Myc proto-oncogen expressing mice [10] lacking caspase-2 develop lymphoma with significantly higher incidence and rate, whereas Kras expressing mice develop lung cancer with increased incidence when caspase-2 is depleted [37].